HCAT
Health Catalyst Inc
1.70$
+1.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.6% | -1.0% | -0.5% | +17.5% | +5.6% | +3.8% | -30.9% | -4.7% | -14.4% | -18.0% | -13.0% | |
| – | -3.7% | +1.0% | -5.3% | +21.6% | +1.8% | -9.2% | -57.3% | -8.4% | +2.4% | +7.7% | +36.2% | |
| – | +11.9% | +89.5% | +0.3% | +62.6% | -24.0% | +37.0% | -85.2% | -20.5% | +26.1% | +17.8% | +1.2% | |
| – | -8.6% | +3.2% | -6.0% | +25.6% | +1.2% | -12.8% | -71.5% | -6.0% | +4.6% | +13.7% | -4.9% | |
| – | +30.8% | -10.6% | +1.9% | -5.9% | +10.7% | +12.0% | +6.8% | -12.1% | -1.6% | +0.0% | -29.2% | |
| – | +0.0% | +0.0% | +0.0% | – | – | – | – | – | – | – | – | |
| – | +2.5% | +0.0% | +8.2% | +13.6% | +10.8% | +20.6% | -8.7% | -0.2% | -26.8% | -45.8% | -90.2% | |
| – | +1.9% | -9.8% | +0.8% | +14.5% | +12.5% | +23.6% | -7.6% | -8.9% | -13.3% | -10.7% | -19.1% | |
| – | +1.3% | +0.9% | -0.9% | +36.8% | +7.8% | +4.3% | -47.8% | -5.0% | +0.6% | +6.7% | -5.9% | |
| – | +5.7% | +3.6% | +244.9% | +1.8% | +0.6% | +4.2% | -70.9% | -11.1% | +1.9% | +20.1% | -14.6% | |
| – | -1.3% | -0.3% | +6,835.4% | +0.7% | +0.4% | +0.2% | -97.7% | -0.4% | -1.4% | -0.9% | -0.6% | |
| – | +5.0% | -14.2% | +86.0% | +34.7% | -19.9% | -21.8% | -0.1% | -44.7% | +89.4% | +24.9% | -28.7% | |
| – | +0.2% | +0.2% | – | – | +31.9% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | |
| – | -4.0% | -2.6% | -0.1% | -0.6% | +2.9% | +3.2% | -7.8% | -4.5% | -26.0% | -43.8% | -27.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.3% | +1.9% | +1.2% | +1.9% | +3.2% | +9.9% | +1.6% | +1.1% | +0.9% | +2.2% | +1.9% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.